F&V Capital Management, LLC / BMY
F&V Capital Management, LLC’s Bristol-Myers Squibb Co Position
Does F&V Capital Management, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 276.5K shares worth $17M (+3.54% of its 13F portfolio) as of Q1 2026, down from 280.1K shares the prior filed quarter.
Position Value
$17M
Q1 2026
Shares
276.5K
% of Portfolio
+3.54%
Quarters Held
24
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 276.5K | $17M | +3.54% |
| Q4 2025 | 280.1K | $15M | +3.21% |
| Q3 2025 | 173.2K | $8M | +1.75% |
| Q2 2025 | 171.0K | $8M | +2.02% |
| Q1 2025 | 170.7K | $10M | +2.70% |
| Q4 2024 | 172.2K | $10M | +2.56% |
| Q3 2024 | 170.6K | $9M | +2.27% |
| Q2 2024 | 167.5K | $7M | +2.03% |
| Q1 2024 | 158.3K | $9M | +2.53% |
| Q4 2023 | 153.8K | $8M | +2.53% |
| Q3 2023 | 153.6K | $9M | +3.06% |
| Q2 2023 | 155.5K | $10M | +3.21% |
| Q1 2023 | 157.1K | $11M | +3.61% |
| Q4 2022 | 150.3K | $11M | +3.60% |
| Q3 2022 | 150.1K | $11M | +4.12% |
| Q2 2022 | 147.4K | $11M | +4.04% |
| Q1 2022 | 142.1K | $10M | +3.15% |
| Q4 2021 | 142.0K | $9M | +2.97% |
| Q3 2021 | 129.6K | $8M | +3.07% |
| Q2 2021 | 127.6K | $9M | +3.13% |
| Q1 2021 | 80.4K | $5M | +1.90% |
| Q4 2020 | 7.3K | $453,000 | +0.20% |
| Q3 2020 | 3.3K | $201,000 | +0.10% |
| Q4 2019 | 3.4K | $220,000 | +0.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See F&V Capital Management, LLC’s full portfolio or all institutional holders of BMY.